- Home
- ACP vs OFIX Comparison
ACP vs OFIX Comparison
Compare ACP & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACP
- OFIX
- Stock Information
- Founded
- ACP 2010
- OFIX 1987
- Country
- ACP United States
- OFIX United States
- Employees
- ACP N/A
- OFIX N/A
- Industry
- ACP Investment Managers
- OFIX Medical/Dental Instruments
- Sector
- ACP Finance
- OFIX Health Care
- Exchange
- ACP Nasdaq
- OFIX Nasdaq
- Market Cap
- ACP 677.5M
- OFIX 648.7M
- IPO Year
- ACP N/A
- OFIX N/A
- Fundamental
- Price
- ACP $5.53
- OFIX $13.03
- Analyst Decision
- ACP
- OFIX Strong Buy
- Analyst Count
- ACP 0
- OFIX 4
- Target Price
- ACP N/A
- OFIX $23.33
- AVG Volume (30 Days)
- ACP 337.9K
- OFIX 251.1K
- Earning Date
- ACP 01-01-0001
- OFIX 05-06-2025
- Dividend Yield
- ACP 17.79%
- OFIX N/A
- EPS Growth
- ACP N/A
- OFIX N/A
- EPS
- ACP N/A
- OFIX N/A
- Revenue
- ACP N/A
- OFIX $799,491,000.00
- Revenue This Year
- ACP N/A
- OFIX $4.87
- Revenue Next Year
- ACP N/A
- OFIX $6.40
- P/E Ratio
- ACP N/A
- OFIX N/A
- Revenue Growth
- ACP N/A
- OFIX 7.08
- 52 Week Low
- ACP $5.55
- OFIX $12.08
- 52 Week High
- ACP $7.17
- OFIX $20.73
- Technical
- Relative Strength Index (RSI)
- ACP 42.42
- OFIX 25.56
- Support Level
- ACP $5.33
- OFIX $12.83
- Resistance Level
- ACP $5.65
- OFIX $14.20
- Average True Range (ATR)
- ACP 0.15
- OFIX 0.85
- MACD
- ACP -0.00
- OFIX -0.18
- Stochastic Oscillator
- ACP 61.00
- OFIX 5.52
About ACP abrdn Income Credit Strategies Fund
abrdn Income Credit Strategies Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income with a secondary objective of capital appreciation. It predominantly invests in debt and loan instruments of issues that operate in a variety of industries and geographic regions.
About OFIX Orthofix Medical Inc. (DE)
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.